NCT06780306 - A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions

Dry EyeDry Eye Disease (DED)Dry Eye Disease With Severe Keratitis

Interventions

BIOLOGICAL

TTAX03

Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord

BIOLOGICAL

Saline (NaCl 0,9 %) (placebo)

300 mL Sterile, preservative free 0.9% NaCl

Trial Locations (10)

28150

RECRUITING

CORE, Inc. / Vita Eye Clinic, Shelby

28451

RECRUITING

Wilmington Eye at Brunswick Forest, Leland

33064

RECRUITING

Advanced Research, LLC., Deerfield Beach

39216

RECRUITING

University of Mississippi Medical Center, Jackson

55318

RECRUITING

Southwest Eye Care, Chaska

78749

RECRUITING

Westlake Eye Specialists, Austin

94720

RECRUITING

University California Berkeley, Berkeley

02747

RECRUITING

Eye Health Vision Center/Claris Vision LLC, South Dartmouth

07801

RECRUITING

Eye Associates of North Jersey, Dover

07079

RECRUITING

Northern New Jersey Eye Institute, South Orange

All Listed Sponsors

lead

BioTissue Holdings, Inc

INDUSTRY